Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Mar 15, 2021; 13(3): 174-184
Published online Mar 15, 2021. doi: 10.4251/wjgo.v13.i3.174
Published online Mar 15, 2021. doi: 10.4251/wjgo.v13.i3.174
Table 1 Comparison of baseline clinicopathologic characteristics between grasping forceps assisted endoscopic resection and endoscopic submucosal dissection groups
GF-ER | ESD | P value | |
Age, yr | |||
Median (IQR) | 68.0 (54-80) | 75.0 (66-82) | 0.28 |
Sex, n (%) | |||
Male | 6 (75.0) | 45 (71.4) | 1 |
Female | 2 (25.0) | 18 (28.6) | |
Morphology, n (%) | |||
Flat or depressed | 5 (55.6) | 46 (73.0) | 0.43 |
Elevated | 4 (44.4) | 17 (27.0) | |
Ulceration, n (%) | |||
Presence | 0 (0) | 4 (6.3) | 1 |
Absence | 9 (100) | 59 (93.7) | |
Tumor size, mm | |||
Median (IQR) | 7 (4-11) | 16 (9-22) | < 0.01 |
Tumor depth, n (%) | |||
Mucosa | 6 (66.7) | 49 (77.8) | 0.43 |
Submucosa | 3 (33.3) | 14 (22.2) | |
Histology, n (%) | |||
Differentiated | 9 (100) | 49 (77.8) | 0.31 |
Undifferentiated | 0 (0) | 14 (22.2) |
Table 2 Comparison of baseline clinicopathologic characteristics between grasping forceps assisted endoscopic resection and endoscopic submucosal dissection groups for small lesions (defined as ≤ 10 mm in diameter)
GF-ER | ESD | P value | |
Age, yr | |||
Median (IQR) | 67.5 (54-80) | 75.5 (66-79) | 0.39 |
Sex, n | |||
Male | 4 (66.7) | 16 (80.0) | 0.60 |
Female | 2 (33.3) | 4 (20.0) | |
Morphology, n (%) | |||
Flat or depressed | 4 (57.1) | 16 (80.0) | 0.33 |
Elevated | 3 (42.9) | 4 (20.0) | |
Ulceration, n (%) | |||
Presence | 0 (0) | 1 (5.0) | 1.0 |
Absence | 7 (100) | 19 (95.0) | |
Tumor size, mm | |||
Median (IQR) | 6.0 (4-8) | 6.5 (5-9) | 0.45 |
Tumor depth, n (%) | |||
Mucosa | 4 (57.1) | 18 (90.0) | 0.09 |
Submucosa | 3 (42.9) | 2 (10.0) | |
Histology, n (%) | |||
Differentiated | 7 (100) | 17 (85.0) | 1.0 |
Undifferentiated | 0 (0) | 3 (15.0) |
Table 3 Comparison of treatment outcomes between grasping forceps assisted endoscopic resection and endoscopic submucosal dissection groups
GF-ER | ESD | P value | |
Procedure time, min | |||
Median (IQR) | 4.0 (3.0-5.0) | 55.0 (30-105) | < 0.01 |
En bloc resection, n (%) | 9 (100) | 63 (100) | 1.0 |
R0 resection, n (%) | 9 (100) | 62 (98.4) | 1.0 |
Curative resection, n (%) | 9 (100) | 55 (87.3) | 0.54 |
Perforation, n (%) | 0 (0) | 5 (8.0) | 1.0 |
Delayed bleeding, n (%) | 0 (0) | 1 (1.6) | 1.0 |
Table 4 Comparison of treatment outcomes for small lesions (defined as ≤ 10 mm in diameter) between grasping forceps assisted endoscopic resection and endoscopic submucosal dissection groups
GF-ER | ESD | P value | |
Procedure time, min | |||
Median (IQR) | 4.0 (3.0-5.0) | 35.0 (25-75) | < 0.01 |
En bloc resection, n (%) | 7 (100) | 20 (100) | 1.0 |
R0 resection, n (%) | 7 (100) | 20 (100) | 1.0 |
Curative resection, n (%) | 7 (100) | 19 (95.0) | 1.0 |
Perforation, n (%) | 0 (0) | 1 (5.0) | 1.0 |
Delayed bleeding, n (%) | 0 (0) | 0 (0) | 1.0 |
- Citation: Ichijima R, Suzuki S, Esaki M, Horii T, Kusano C, Ikehara H, Gotoda T. Efficacy and safety of grasping forceps-assisted endoscopic resection for gastric neoplasms: A multi-centre retrospective study. World J Gastrointest Oncol 2021; 13(3): 174-184
- URL: https://www.wjgnet.com/1948-5204/full/v13/i3/174.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i3.174